Episode Player
Ke-Wu Zeng on molecular glues for cancer therapy
eBioMedicine in conversation with
eBioMedicine in conversation with
Ke-Wu Zeng on molecular glues for cancer therapy
Jan 18, 2023
eBioMedicine
Drs Zeng join eBioMedicine to discuss their study of a novel molecular glue, called bufalin.
Read the full article:
Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv